A new study provides the first evidence demonstrating the activation of brain cells by covid-19 virus spike protein.
How the spike protein used by the coronavirus to enter human cells can have a similar effect on the brain’s immune cells is described by Huddersfield researchers in the study published in the journal Molecular Neurobiology. Their previous research discovered how the onset of Alzheimer's disease can be slowed and some of its symptoms curbed by a natural compound that is found in pomegranate.
‘The activation of brain cells by COVID-19 virus spike protein resulted in the increased release of various inflammatory markers, which are hallmarks of neuroinflammation.’
Following this hypothesis, researchers are now questioning whether coronavirus affects the brain, could pose a risk for neurodegenerative disorders further down the line, like Alzheimer's or Parkinson's.Oher research demonstrated the mechanism of why the virus was able to gain access into the brain through the nose, but this was the first to demonstrate how the coronavirus activated the brain's immune response.
The COVID-19 virus may not be multiplying in the brain, but when it gets into the brain, it can induce immune responses and this explains some of the trends people have reported when they have been infected such as continued brain fog and memory loss.
In this study, they investigated the effects of the SARS‐CoV‐2 spike protein S1 stimulation on neuroinflammation in brain nerve cells.
Results of the experiment show that the recombinant SARS-CoV-2 spike protein sub-unit S1 activated BV-2 microglia as demonstrated by an increase in the protein expression of Iba-1, which is mainly expressed by the microglia and increased by the activation of these cells.
Advertisement
Elevated iNOS/NO has been previously linked to a wide range of CNS disorders including Alzheimer’s disease, Parkinson’s disease, multiple sclerosis, epilepsy, and migraine.
Advertisement
These results contribute to our understanding of some of the mechanisms involved in CNS pathologies of SARS-CoV-2.
Source-Medindia